Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T13:30:58.024Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of Methadone Therapy on Changing of Positive and Negative Mood Affect in Addicted People

Published online by Cambridge University Press:  16 April 2020

S.J. Mosavi Amiri ,
A. Homayuoni ,
S. Soleimani Amiri ,
G.A. Nikpour  and
A. Khanmohammadi
S.J. Mosavi Amiri
Affiliation:
Addiction Studies, Medical Clinic of Dr. Mosavi, Babol (Amirkola), Iran
A. Homayuoni
Affiliation:
Psychology, Islamic Azad University Bandargaz Branch, Bandargaz, Iran
S. Soleimani Amiri
Affiliation:
Addiction Studies, Medical Clinic of Dr. Mosavi, Babol (Amirkola), Iran
G.A. Nikpour
Affiliation:
Psychology, Islamic Azad University Sari Branch, Sari, Iran
A. Khanmohammadi
Affiliation:
Psychology, Islamic Azad University Ayatollah Amoli Branch, Amol, Iran

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aim:

The study aimed to investigate effects of drug named methadone in treating of addicted on changing of positive and negative mood affect.

Method:

19 addicted people were randomly selected and before methadone therapy with a pretest, Watson’s Positive Affect and Negative Affect (PANAS) was administered on them. One month later after methadone therapy, again Watson’s Positive Affect and Negative Affect (PANAS) was administered on them. PANAS assesses: Interest, Distress, Powerfulness, Fear, Enthusiasm, Proud, Agitation, Nervous, Panic. Data was analyzed with independent T test.

Results:

Findings showed significant differences between PANAS components. Methadone therapy increase interest, powerfulness, enthusiasm, proud, and decreased distress, agitation, panic. But there is not any differences between fear and nervous in pre and post test.

Discussion:

The findings indicated using methadone drug in addition to reduce physical symptoms can reduce significantly mental problems in addicted and can be regarded a proficient drug for treating of addiction.

Type
P01-56
Information
European Psychiatry , Volume 24 , Issue S1: 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract book , January 2009 , 24-E444
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.